LTRO. please correct if I have this wrong ...but my reading is
The above group ...roughly 800,000 patients are covered ....but if you are simply high cardio risk and your TG's are lower than 150 mg/dl ...you are not covered .
This is what I've seen more recently in the US as well among a couple of friends who had MI's , now stented ...but not on Vascepa . Why ? TG's under 150mg/dl on optimal statin therapy
LTRO. on reading the google translate from Laurent ...they are saying that LDL levels could have been lowered further ( max statin dose or adding ezetimibe to drive LDL below 70 and closer to 55 mg/dl ) therefore AMRN has not proven benefit from the R-IT trial . Just my take Kiwi